Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E Adjustments
Ratios

Contineum Therapeutics (CTNM) Accumulated Depreciation & Amortization (2023 - 2024)

Contineum Therapeutics (CTNM) has 2 years of Accumulated Depreciation & Amortization data on record, last reported at $300000.0 in Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization fell 79.69% year-over-year to $300000.0; the TTM value through Dec 2024 reached $300000.0, down 79.69%, while the annual FY2024 figure was $300000.0, 79.69% down from the prior year.
  • Accumulated Depreciation & Amortization reached $300000.0 in Q4 2024 per CTNM's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.5 million in Q4 2023 and bottomed at $300000.0 in Q4 2024.